Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tolerability and Immunogenicity of Fluval P Monovalent Influenza Vaccine

This study has been completed.
Information provided by (Responsible Party):
Omninvest Vaccine Manufacturing, Researching and Trading Ltd. Identifier:
First received: November 7, 2009
Last updated: May 18, 2012
Last verified: May 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2010
  Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):